Statistici de bază
| CIK | 1623077 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to PixarBio Corporation
SEC Filings (Chronological Order)
Această pagină oferă o listă completă, cronologică, a dosarelor SEC, cu excepția dosarelor de proprietate pe care le oferim în altă parte.
| October 30, 2018 |
begin 644 filename1 M)5!$1BTQ+C8-)>+CS],-"C0V(# @;V)J#3P\+TQI;F5A(G"U]=O/#Y@ 6]IN0F"X^ON?(/Q@$#BX P#BP&'L? MYC"G,5QN-2,X@BE1;YO@88HK2N5)/6O M^QG3M4P. |
|
| February 21, 2018 |
Form 8K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| February 15, 2018 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 9, 2018 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Employer Iden |
|
| December 28, 2017 |
8-K 1 f8k1228178k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 21, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Org |
|
| December 21, 2017 |
8-K 1 f8k1221178k.htm FORM 8K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 17, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorp |
|
| December 21, 2017 |
Exhibit 17 Email from Derek Bridges dated December 17, 2017 at 9:46pm From: Derek Bridges [mailto:dbridges@pixarbio. |
|
| June 16, 2017 |
Form 8K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| May 5, 2017 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 3, 2017 |
BMP Hldgs FORM 12B25 NOTICE OF LATE FILING UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One): X . Form 10-K . Form 20-F . Form 11-K . Form 10-Q . Form 10-D . Form N-SAR . Form N-CSR For Period Ended: December 31, 2016 . Transition Report on Form 10-K . Transition Report on Form 20-F . Transition Report on Form 11-K . Transition Report on Form 10-Q . Transition Report |
|
| March 21, 2017 |
BMP Hldgs FORM 8-K (Current Report/Significant Event) pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 20, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Empl |
|
| March 21, 2017 |
pxrbex991.htm EXHIBIT 99.1 March 20, 2017 Dear PixarBio Shareholder: We are pleased to provide you with the following updates on our business developments and regulatory matters: Q1 2017 has been a productive quarter for PixarBio in achieving our objective of commencing human studies in 2018 with FDA approval expected in late 2018 or early 2019. After 2+ years of working with partners we selected |
|
| March 10, 2017 |
pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): March 6, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Emplo |
|
| March 1, 2017 |
pxrbex991.htm EXHIBIT 99.1 |
|
| March 1, 2017 |
EX-99.1 2 pxrbex991.htm PRE-CLINICAL DATA PRESENTATION EXHIBIT 99.1 1 2 3 4 5 6 7 8 9 10 11 |
|
| March 1, 2017 |
8-K 1 pxrb8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 25, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organiza |
|
| March 1, 2017 |
BMP Hldgs FORM 8-K/A (Current Report/Significant Event) pxrb8ka.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 28, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Orga |
|
| February 10, 2017 |
8-K 1 pxrb8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 3, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organizat |
|
| February 9, 2017 |
pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): February 2, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Em |
|
| January 30, 2017 |
Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Em |
|
| January 30, 2017 |
pxrbex991.htm EXHIBIT 99.1 CONTACT: Ken Stromsland CIO and VP, Investor & Public Relations (617) 913-8884 [email protected] PixarBio Corporation Securities Temporarily Suspended From Trading By The Securities and Exchange Commission Cambridge, Massachusetts (January 27, 2017): PixarBio Corporation (formerly traded on OTCQX as PXRB) announced today that, pursuant to a January 23, 2017 Order, tradin |
|
| January 30, 2017 |
Regulation FD Disclosure, Financial Statements and Exhibits pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Em |
|
| January 26, 2017 |
EX-99.1 2 pxrbex991.htm PRESS RELEASE EXHIBIT 99.1 CONTACT: Ken Stromsland CIO and VP, Investor & Public Relations (617) 913-8884 [email protected] PixarBio Corporation Terminates InVivo Therapeutics Bid Jan 23, 2017 OTC Disclosure & News Service PixarBio Corporation, (OTCQX:PXRB) today announced that we will stay focused on our NeuroRelease Pain platform and continue to drive our non-opiate non a |
|
| January 26, 2017 |
Financial Statements and Exhibits pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 23, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Em |
|
| January 10, 2017 |
8-K 1 pxrb8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 9, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organizati |
|
| January 10, 2017 |
pxrbex991.htm EXHIBIT 99.1 PixarBio Corporation Expands Non-Opiate R&D Portfolio for Pain with Steroid Injections; Collaborates for Clinical cGMP Manufacturing, and Grooms Team for Clinical Studies of NeuroRelease Post-Surgical Pain Treatments 14-Day, 7-Day, and 3-Day Posted on January 09, 2017 Cambridge, Massachusetts (January 9, 2017): PixarBio Corporation, (OTCQX:PXRB) today announced the expan |
|
| January 5, 2017 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 4, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Employer Ident |
|
| January 5, 2017 |
pxrbex991.htm EXHIBIT 99.1 CONTACT: Ken Stromsland CIO and VP, Investor & Public Relations (617) 913-8884 [email protected] PixarBio Corporation (?PixarBio?) Entered into an Agreement with Henry Sargent, to Sell to Him all of the Membership Interests in PixarBio?s Wholly Owned Subsidiary Buddhi Mat LLC Cambridge, Massachusetts (January 5, 2017): PixarBio Corporation, (OTCQX: PXRB) developers of Ne |
|
| January 5, 2017 |
PixarBio Corporation Responds to InVivo Therapeutics False Patent and Intellectual Property Claims EX-99.1 2 pxrbex991.htm PRESS RELEASE EXHIBIT 99.1 PixarBio Corporation Responds to InVivo Therapeutics False Patent and Intellectual Property Claims Posted on January 4, 2017 Cambridge, Massachusetts (January 4, 2017): PixarBio Corporation, (OTCQX: PXRB) developers of NeuroReleaseTM, a morphine replacement, non-opiate/opioid, non-addictive pain treatment with FDA approval expected in early 2019, |
|
| January 5, 2017 |
8-K 1 pxrb8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): December 30, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organiza |
|
| January 3, 2017 |
EX-99.1 2 pxrbex991.htm PRESS RELEASE EXHIBIT 99.1 CONTACT: Ken Stromsland CIO and VP, Investor & Public Relations (617) 913-8884 [email protected] It’s Time to Make US Pharma GREAT Again, By Combining Two Frank Reynolds’ Founded Pharmas, PixarBio Corp (OTCQX:PXRB) and InVivo Therapeutics (NASDAQ:NVIV). The $77,000,000 Stock Offer Will Create a New Pharma Called Reynolds Therapeutics Corporation t |
|
| January 3, 2017 |
pxrb8k.htm UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): January 3, 2017 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Emp |
|
| December 27, 2016 |
Regulation FD Disclosure, Financial Statements and Exhibits Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 27, 2016 |
Exhibit 99.1 Press Release |
|
| November 29, 2016 |
Financial Statements and Exhibits 8-K 1 f8k1128168k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 28, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incor |
|
| November 29, 2016 |
Exhibit 99.3 Press Release |
|
| November 25, 2016 |
As filed with the Securities and Exchange Commission on November 25, 2016 Form S-1 Registration Statement As filed with the Securities and Exchange Commission on November 25, 2016 Registration No. |
|
| November 23, 2016 |
Financial Statements and Exhibits, Changes in Registrant's Certifying Accountant UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 14, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Employer Iden |
|
| November 23, 2016 |
Exhibit 16.1 Auditor's Letter |
|
| November 15, 2016 |
BMP Hldgs FORM 10-Q QUARTERLY REPORT (Quarterly Report) Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| November 15, 2016 |
BMP Hldgs FORM 12B25 NOTICE OF LATE FILING Form 12b25 Notice of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| November 9, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Employer Iden |
|
| November 9, 2016 |
EX-99.1 2 f8k110816ex99z1.htm EXHIBIT 99.1 PRESS RELEASE |
|
| November 8, 2016 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): November 7, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorporation or Organization) (I.R.S. Employer Iden |
|
| November 8, 2016 |
EX-99.1 2 f8k110716ex99z1.htm EXHIBIT 99.1 PRESS RELEASE |
|
| November 4, 2016 |
EX-2.2 4 f8k110216ex2z2.htm EXHIBIT 2.2 AGREEMENT AND PLAN OF MERGER |
|
| November 4, 2016 |
Exhibit 4.2 Form of Placement Agent Warrant |
|
| November 4, 2016 |
EX-10.11 18 f8k110216ex10z11.htm EXHIBIT 10.11 BOARD OF DIRECTORS AGREEMENT |
|
| November 4, 2016 |
EX-10.10 17 f8k110216ex10z10.htm EXHIBIT 10.10 BOARD OF DIRECTORS AGREEMENT |
|
| November 4, 2016 |
Exhibit 1.1 Placement Agent Agreement |
|
| November 4, 2016 |
Exhibit 10.6 Lease Agreement |
|
| November 4, 2016 |
Exhibit 10.12 Board of Directors Agreement |
|
| November 4, 2016 |
Exhibit 10.8 Employment Agreement |
|
| November 4, 2016 |
Exhibit 10.4 Lease Agreement |
|
| November 4, 2016 |
EX-2.3 5 f8k110216ex2z3.htm EXHIBIT 2.3 ARTICLES OF MERGER |
|
| November 4, 2016 |
EX-21.1 23 f8k110216ex21z1.htm EXHIBI 21.1 LIST OF SUBSIDIARIES |
|
| November 4, 2016 |
EX-2.1 3 f8k110216ex2z1.htm EXHIBIT 2.1 AGREEMENT AND PLAN OF MERGER |
|
| November 4, 2016 |
Completion of Acquisition or Disposition of Assets 8-K 1 f8k1102168k.htm FORM 8-K CURRENT REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of Earliest Event Reported): October 31, 2016 PixarBio Corporation (Name of Small Business Issuer in its Charter) Delaware 47-1945113 (State or Jurisdiction of Incorp |
|
| November 4, 2016 |
Exhibit 10.9 Employment Agreement |
|
| November 4, 2016 | ||
| November 4, 2016 |
EX-4.1 8 f8k110216ex4z1.htm EXHIBIT 4.1 FORM OF INVESTOR WARRANT |
|
| November 4, 2016 |
Exhibit 10.5 Lease Agreement |
|
| November 4, 2016 |
Exhibit 10.14 Equity Incentive Plan |
|
| November 4, 2016 |
Exhibit 2.4 Articles of Merger |
|
| November 4, 2016 |
Exhibit 10.7 Employment Agreement |
|
| November 4, 2016 |
EX-2.5 7 f8k110216ex2z5.htm EXHIBIT 2.5 CERTIFICATE OF MERGER |
|
| November 4, 2016 |
Exhibit 10.3 Lease Agreement |
|
| November 4, 2016 |
EX-10.13 20 f8k110216ex10z13.htm EXHIBIT 10.13 CONSULTING AGREEMENT |
|
| October 31, 2016 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| October 31, 2016 |
Exhibit 99.1 Press Release CONTACT: Ken Stromsland CIO and VP, Investor & Public Relations (617) 913-8884 [email protected] PixarBio Corporation, Finalized its Merger Transaction with BMP Holdings, Stock Trading on The OTC Markets Begins Monday October 31, 2016 Under New Stock Symbol PXRB Cambridge, Massachusetts (October 30, 2016): PixarBio Corporation, inventor of NeuroReleaseTM, a morphine repl |
|
| October 14, 2016 |
BMP Hldgs FORM 8-K CURRENT REPORT (Current Report/Significant Event) Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 29, 2016 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| September 2, 2016 |
Schedule 14f-1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 Schedule 14F-1 INFORMATION STATEMENT PURSUANT TO SECTION 14(f) OF THE SECURITIES EXCHANGE ACT OF 1934 AND RULE 14f-1 THEREUNDER BMP HOLDINGS INC. (Exact name of registrant as specified in its corporate charter) Commission File No.: 333-204070 Delaware (State or other jurisdiction of incorporation or organization |
|
| September 1, 2016 |
BMPP / BMP Hldgs Inc / REYNOLDS FRANCIS - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 BMP HOLDINGS INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 05581G 100 (CUSIP Number) PixarBio Corporation (617) 401-0050 200 Boston Avenue Suite 1875 Medford, MA 02155 (Name, Address and Telephone Number of Pers |
|
| September 1, 2016 |
BMPP / BMP Hldgs Inc / Pixarbio Corp - SCHEDULE 13D Activist Investment Schedule 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 BMP HOLDINGS INC. (Name of Issuer) Common Stock, Par Value $0.0001 Per Share (Title of Class of Securities) 05581G 100 (CUSIP Number) PixarBio Corporation (617) 401-0050 200 Boston Avenue Suite 1875 Medford, MA 02155 (Name, Address and Telephone Number of Pers |
|
| August 26, 2016 |
Form 8-K Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| August 26, 2016 |
Exhibit 10.1 Management Agreement Exhibit 10.1 MANAGEMENT AGREEMENT AGREEMENT made as of this 19th day of August, 2016, by and between HENRY SARGENT, having an address at 381 West Mountain Road, Ridgefield, CT 06877 (?Sargent?), BMP Holdings Inc. (?BMP?),and Buddhi Mat LLC, a Connecticut limited liability company, having an office at 381 West Mountain Road, Ridgefield, CT 06877 (the ?Company?) (th |
|
| August 16, 2016 |
BMP Hldgs FORM 10-Q/A AMENDED QUARTERLY REPORT (Quarterly Report) UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the six month period ended June 30, 2016 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BMP HOLDINGS, INC. (Exact name of registrant as specified in its ch |
|
| August 15, 2016 |
BMP Hldgs FORM 10-Q QUARTERLY REPORT (Quarterly Report) Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| June 29, 2016 |
BMP Hldgs FORM 10-Q QUARTERLY REPORT (Quarterly Report) 10-Q/A 1 f10qa06301510qz.htm FORM 10-Q QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q/A Amendment No. 1 (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the six month period ended June 30, 2015 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BMP HOLDING |
|
| June 29, 2016 |
BMP Hldgs FORM 10-Q QUARTERLY REPORT (Quarterly Report) Form 10-Q Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 25, 2016 |
BMP Hldgs FORM 10-Q/A AMENDED QUARTERLY REPORT (Quarterly Report) Form 10-Q/A Amended Quarterly Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D. |
|
| May 23, 2016 |
BMP Hldgs FORM 10-Q QUARTERLY REPORT (Quarterly Report) 10-Q 1 f10q03311610q.htm FORM 10-Q QUARTERLY REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the three month period ended March 31, 2016 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BMP HOLDINGS INC. (Exact name of registra |
|
| May 16, 2016 |
BMP Hldgs FORM 12B25 NOTICE OF LATE FILING Form 12b25 Notice of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| April 13, 2016 |
BMP Hldgs FORM 10-K ANNUAL REPORT (Annual Report) 10-K 1 f10k12311510k.htm FORM 10-K ANNUAL REPORT UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 BMP HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 47-1945113 (State or jurisdiction of (I.R.S. Employer inco |
|
| March 29, 2016 |
BMP Hldgs FORM 12B25 NOTICE OF LATE FILING Form 12b25 Notice of Late Filing UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| December 11, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q X . QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the nine month period ended September 30, 2015 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BMP HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 47-19451 |
|
| November 3, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) X . QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the six month period ended June 30, 2015 . TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 BMP HOLDINGS, INC. (Exact name of registrant as specified in its charter) Delaware 47 |
|
| August 12, 2015 |
BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 August 12, 2015 VIA EDGAR ONLY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John Dana Brown Julie Griffith Theresa Messinese Lyn Shenk Re: BMP Holdings Inc. Amendment No.3 to Registration Statement on Form S-1 Filed August 5, 2015 File No. 333-204070 L |
|
| August 12, 2015 |
Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Licensed in New York Of Counsel: and New Jersey Mintz & Fraade, P.C. 488 Madison Avenue New York, N.Y. 10022 (212) 486-2500 August 12, 2015 VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John |
|
| August 12, 2015 |
BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 August 12, 2015 VIA EDGAR ONLY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John Dana Brown Julie Griffith Theresa Messinese Lyn Shenk Re: BMP Holdings Inc. Amendment No.3 to Registration Statement on Form S-1 Filed August 5, 2015 File No. 333-204070 L |
|
| August 7, 2015 |
August 7, 2015 Henry Sargent Chief Executive Officer BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 Re: BMP Holdings Inc. Amendment No. 3 to Registration Statement on Form S-1 Filed August 5, 2015 File No. 333-204070 Dear Mr. Sargent: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with inform |
|
| August 5, 2015 |
Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Licensed in New York Of Counsel: and New Jersey Mintz & Fraade, P.C. 488 Madison Avenue New York, N.Y. 10022 (212) 486-2500 August 4, 2015 VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John |
|
| August 5, 2015 |
As filed with the Securities and Exchange Commission on August 4, 2015 As filed with the Securities and Exchange Commission on August 4, 2015 Registration No. |
|
| July 30, 2015 |
July 30, 2105 Henry Sargent Chief Executive Officer BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 Re: BMP Holdings Inc. Amendment No. 2 to Registration Statement on Form S-1 Filed July 23, 2015 File No. 333-204070 Dear Mr. Sargent: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with informat |
|
| July 23, 2015 |
As filed with the Securities and Exchange Commission on July 23, 2015 S-1/A 1 s101505s1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on July 23, 2015 Registration No. 333-204070 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BMP HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 8129 47-1945113 (State or juri |
|
| July 23, 2015 |
Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Licensed in New York Of Counsel: and New Jersey Mintz & Fraade, P.C. 488 Madison Avenue New York, N.Y. 10022 (212) 486-2500 July 23, 2015 VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John D |
|
| July 13, 2015 |
July 13, 2015 Henry Sargent Chief Executive Officer BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 Re: BMP Holdings Inc. Amendment No. 1 to Registration Statement on Form S-1 Filed June 29, 2015 File No. 333-204070 Dear Mr. Sargent: We have reviewed your amended registration statement and have the following comments. In some of our comments, we may ask you to provide us with informat |
|
| June 29, 2015 |
As filed with the Securities and Exchange Commission on June 25, 2015 Registration No. |
|
| June 29, 2015 |
Joseph J. Tomasek, Esq. 77 North Bridge Street Somerville, New Jersey 08876 (973) 224-1061 Licensed in New York Of Counsel: and New Jersey Mintz & Fraade, P.C. 488 Madison Avenue New York, N.Y. 10022 (212) 486-2500 June 29, 2015 VIA EDGAR AND OVERNIGHT DELIVERY United States Securities and Exchange Commission Division of Corporation finance 100 F Street, NE Washington, D.C. 20549 Attention: John D |
|
| June 8, 2015 |
June 5, 2015 Henry Sargent Chief Executive Officer BMP Holdings Inc. 381 West Mountain Rd. Ridgefield, CT 06877 Re: BMP Holdings Inc. Registration Statement on Form S-1 Filed May 11, 2015 File No. 333-204070 Dear Mr. Sargent: We have reviewed your registration statement and have the following comments. In some of our comments, we may ask you to provide us with information so we may better understa |
|
| May 11, 2015 |
EXHIBIT 10.2 THIS LEASE, dated this 10th day of August, 2009, by and between NORFOLK COMPANY, LLC acting herein by Paul S. McNamara, its Member (hereinafter called "LESSOR") and BUDDHI-MAT LLC, a Connecticut limited liability company, acting herein by Henry Sargent, its Manager, having its principal place of business at 66 Danbury Road, Ridgefield, CT 06877, (hereinafter called "LESSEE"), and HENR |
|
| May 11, 2015 |
EXHIBIT 3.1 EXHIBIT 3.1State of Delaware Secretary of State Division of Corporations Delivered 05:29 PM 08/04/2014 FILED 05:29 PM 08/04/2014 SRV 141033349 - 5580652 FILE STATE of DELAWARE CERTIFICATE of INCORPORATION STOCK CORPORATION First: The name of this Corporation is: BMP Holdings Inc. Second: Its registered office in the State of Delaware is to be located at: 1521 Concord Pike #303 Street, |
|
| May 11, 2015 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 BMP HOLDINGS INC. (Exact name of registrant as specified in its charter) Delaware 8129 47-1945113 (State or jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification No.) 381 W. Mountai |
|
| May 11, 2015 |
EX-10.1 5 v410070ex10-1.htm EXHIBIT 10.1 EXHIBIT 10.1 CONTRIBUTION AGREEMENT THIS CONTRIBUTION AGREEMENT (“Agreement”) made as of the 1st day of January 2015, by and between the undersigned who is the holder of the Membership Interest of Buddhi Mat LLC, a limited liability company organized under the laws of Connecticut, (collectively, the “Contributor”), and BMP Holdings Inc., a Delaware corporat |
|
| May 11, 2015 |
BMP HOLDINGS INC. (A DELAWARE CORPORATION) ARTICLE I EX-3.2 3 v410070ex3-2.htm EXHIBIT 3.2 EXHIBIT 3.2 BYLAWS OF BMP HOLDINGS INC. (A DELAWARE CORPORATION) ARTICLE I OFFICES Section 1. Registered Office. The registered office of the corporation in the State of Delaware shall be in the c/o A Registered Agent Inc., 1521 Concord Pike, #303, Wilmington, DE 19803. Section 2. Other Offices. The corporation shall also have and maintain an office or princip |
